Hand holding a pen over graphs depicted on paper.


National coverage for a broad range of patients

WATCHMAN is covered nationally for a broad range of patients by Centers for Medicare & Medicaid Services (CMS) and an ever-increasing number of commercial insurers.

WATCHMAN is covered for patients who need an alternative to oral anticoagulants (OACs), including those with an active lifestyle, a physical occupation, trouble maintaining a stable International Normalized Ratio (INR), or problems with treatment compliance.

CMS will cover LAAC for patients when the following criteria are met:*

1. Increased risk for stroke
CHADS2 score ≥ 2 or a CHA2DS2-VASc score ≥ 3

2. Suitable for short-term warfarin
But deemed unable to take long-term oral anticoagulation

3. Formal shared decision making interaction
Documented evidence of a formal interaction between the patient and an independent non-interventional physician using an OAC evidence-based decision tool

* documented in medical record

WATCHMAN-covered lives: ~120 million

patients icon

~120 million patients covered through Medicare and commercial insurers

Close up of WATCHMAN device with teal overlay.